You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API DACOMITINIB

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing DACOMITINIB

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	CELLULOSE, MICROCRYSTALLINE	2028-08-26
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	FD&C BLUE NO. 2	2028-08-26
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	LACTOSE MONOHYDRATE	2028-08-26
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	MAGNESIUM STEARATE	2028-08-26
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	POLYETHYLENE GLYCOL 3350	2028-08-26
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	POLYVINYL ALCOHOL	2028-08-26
Pfizer Laboratories Div Pfizer Inc	VIZIMPRO	dacomitinib	0069-0197	SODIUM STARCH GLYCOLATE TYPE A POTATO	2028-08-26
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for DACOMITINIB

Excipient focus: CELLULOSE, MICROCRYSTALLINE

DACOMITINIB drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 2

DACOMITINIB drug variants containing FD&C BLUE NO. 2

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing FD&C BLUE NO. 2

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

DACOMITINIB drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

DACOMITINIB drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 3350

DACOMITINIB drug variants containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

DACOMITINIB drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

DACOMITINIB drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

DACOMITINIB drug variants containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

DACOMITINIB drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Pfizer Laboratories Div Pfizer Inc	dacomitinib	0069-0197
US Pharmaceuticals	dacomitinib	63539-197
>Company	>Ingredient	>NDC

DACOMITINIB drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.